To test this hypothesis, we have examined the levels of HSPs and their client proteins (HSP90, HSP70, HSP70, HSP60, HSP40, CDC37, P23, FKBP51, etc.)in HD, tauopathies, and AD animal models of neurodegenerative diseases. This evidence concerns the gene FKBP5 and Alzheimer disease.